FDA Inspection 1056813 — AbbVie Bioresearch Center
The FDA completed an inspection of AbbVie Bioresearch Center on May 24, 2018 in Worcester, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 24, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Worcester, MA (United States)